Differentially expressed plasma MicroRNAs and the potential regulatory function of Let-7b in chronic thromboembolic pulmonary hypertension

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Guo, Lijuan ^a,b   Yang, Yuanhua ^a,b   Liu, Jie ^b   Wang, Lei ^a,b   Li, Jifeng ^a,b   Wang, Ying ^a   Liu, Yan ^a   Gu, Song ^a   Gan, Huili ^b,c   Cai, Jun ^a   Yuan, Jason X J ^d   Wang, Jun ^a,b   Wang, Chen ^a,b,e  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; MICRORNA; MICRORNA 106B; MICRORNA 1260; MICRORNA 129 5P; MICRORNA 140 3P; MICRORNA 1908; MICRORNA 22; MICRORNA 483 5P; MICRORNA 602; MICRORNA 93; MICRORNA LET 7B; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; MIRNLET7 MICRORNA, HUMAN; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; TGF-BETA TYPE I RECEPTOR; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER MODEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ET 1 GENE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE ONTOLOGY; GENE TARGETING; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; PROTEIN EXPRESSION; PULMONARY ARTERIAL ENDOTHELIAL CELL; PULMONARY ARTERIAL SMOOTH MUSCLE CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE FIBER; TGFBR1 GENE; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING; CASE CONTROL STUDY; CELL CULTURE; CELL MOTION; CHRONIC DISEASE; GENETICS; LUNG EMBOLISM; METABOLISM; MIDDLE AGED; PATHOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION;

ADULT; CASE-CONTROL STUDIES; CELL MOVEMENT; CELLS, CULTURED; CHRONIC DISEASE; ENDOTHELIAL CELLS; ENDOTHELIN-1; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MICRORNAS; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PULMONARY ARTERY; PULMONARY EMBOLISM; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84903643336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101055     Document Type: Article

References (52)

1. Fedullo PF, Auger WR, Kerr KM, Rubin LJ (2001) Chronic thromboembolic pulmonary hypertension. N Engl J Med 345: 1465-1472.
2. Peacock A, Simonneau G, Rubin L (2006) Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3: 608-614.
3. Lang I (2010) Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. Br J Haematol 149: 478-483.
4. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, et al. (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350: 2257-2264.
5. Dentali F, Donadini M, Gianni M, Bertolini A, Squizzato A, et al. (2009) Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 124: 256-258.
6. Surie S, Gibson NS, Gerdes VE, Bouma BJ, van Eck-Smit BL, et al. (2010) Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. Thromb Res 125: e202-205.
7. Riedel M, Stanek V, Widimsky J, Prerovsky I (1982) Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 81: 151-158.
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Wang L, Guo LJ, Liu J, Wang W, Yuan JX, et al. (2013) MicroRNA expression profile of pulmonray artery smooth muscle cells and the effect of let-7d in chronic thromboembolic pulmonary hypertension. Pulm Circ 3: 654-664.
10. Chen Z, Nakajima T, Tanabe N, Hinohara K, Sakao S, et al. (2010) Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene. Hum Genet 128: 443-452.
11. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, et al. (2010) Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30: 716-723.
12. Yang S, Banerjee S, De Freitas A, Cui H, Xie N, et al. (2012) miR-21 regulates chronic hypoxia induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 302: 521-529.
13. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, et al. (2010) Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 5: e13247.
14. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, et al. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452.
15. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
16. Xiao J, Jing ZC, Ellinor PT, Liang D, Zhang H, et al. (2011) MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med 9: 159.
17. Sacks RS, Remillard CV, Agange N, Auger WR, Thistlethwaite PA, et al. (2006) Molecular biology of chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 18: 265-276.
18. Reesink HJ, Meijer RC, Lutter R, Boomsma F, Jansen HM, et al. (2006) Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J 70: 1058-1063.
19. Ogawa A, Firth AL, Yao W, Madani MM, Kerr KM, et al. (2009) Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 297: L666-676.
20. Confalonieri M, Kodric M, Longo C, Vassallo FG (2009) Bosentan for chronic thromboembolic pulmonary hypertension. Expert Rev Cardiovasc Ther 7: 1503-1512.
21. Thomas M, Docx C, Holmes AM, Beach S, Duggan N, et al. (2009) Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline. Am J Pathol 174: 380-389.
22. Long L, Crosby A, Yang X, Southwood M, Upton PD, et al. (2009) Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation 119: 566-576.
23. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, et al. (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43: 40S-47S.
24. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
25. Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, et al. (2005) Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res 65: 8142-8150.
26. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
27. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-280.
28. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG (2009) DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 25: 1991-1993.
29. Lauder H, Frost EE, Hiley CR, Fan TP (1998) Quantification of the repair process involved in the repair of a cell monolayer using an in vitro model of mechanical injury. Angiogenesis 2: 67-80.
30. Castanares C, Redondo-Horcajo M, Magan-Marchal N, Lamas S, Rodriguez-Pascual F (2006) Transforming growth factor-beta receptor requirements for the induction of the endothelin-1 gene. Exp Biol Med (Maywood) 231: 700-703.
31. Bonderman D, Wilkens H, Wakounig S, Schafers HJ, Jansa P, et al. (2009) Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 33: 325-331.
32. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, et al. (2008) Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177: 1122-1127.
33. Skoro-Sajer N, Mittermayer F, Panzenboeck A, Bonderman D, Sadushi R, et al. (2007) Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 176: 1154-1160.
34. Arunthari V, Burger CD (2009) Utility of d-dimer in the diagnosis of patients with chronic thromboembolic pulmonary hypertension. Open Respir Med J 3: 85-89.
35. Lankeit M, Dellas C, Panzenbock A, Skoro-Sajer N, Bonderman D, et al. (2008) Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur Respir J 31: 1024-1029.
36. Reesink HJ, Tulevski, II, Marcus JT, Boomsma F, Kloek JJ, et al. (2007) Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 84: 537-543.
37. Aldea M, Clofent J, Nunez de Arenas C, Chamorro M, Velasco M, et al. (2011) Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer. Cancer Lett 311: 210-218.
38. Kittleson MM, Hare JM (2005) Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Trends Cardiovasc Med 15: 130-138.
39. Youssef YM, White NM, Grigull J, Krizova A, Samy C, et al. (2011) Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur Urol 59: 721-730.
40. Liu N, Chen NY, Cui RX, Li WF, Li Y, et al. (2012) Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol 13: 633-641.
41. Kroh EM, Parkin RK, Mitchell PS, Tewari M (2010) Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301.
42. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M (2008) MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18: 549-557.
43. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
44. Rodriguez-Pascual F, Busnadiego O, Lagares D, Lamas S (2011) Role of endothelin in the cardiovascular system. Pharmacol Res 63: 463-472.
45. Wang C, Wang J, Zhao L, Wang Y, Liu J, et al. (2008) Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca2+ entry. J Pharmacol Sci 108: 71-78.
46. Langer F, Bauer M, Tscholl D, Schramm R, Kunihara T, et al. (2005) Circulating big endothelin-1: an active role in pulmonary thromboendarterectomy? J Thorac Cardiovasc Surg 130: 1342-1347.
47. Dupuis J, Hoeper MM (2008) Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 31: 407-415.
48. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, et al. (1989) Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159: 1435-1440.
49. Castanares C, Redondo-Horcajo M, Magan-Marchal N, ten Dijke P, Lamas S, et al. (2007) Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation. J Cell Sci 120: 1256-1266.
50. Jachec W, Foremny A, Domal-Kwiatkowska D, Smolik S, Tomasik A, et al. (2008) Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Int J Mol Med 21: 99-107.
51. Tsai S, Hollenbeck ST, Ryer EJ, Edlin R, Yamanouchi D, et al. (2009) TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am J Physiol Heart Circ Physiol 297: H540-549.
52. Shi X, Direnzo D, Guo LW, Franco SR, Wang B, et al. (2014) TGF-beta/ Smad3 Stimulates Stem Cell/Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation. PLoS One 9: e93995.